Our in vivo data derived from the different animal models, which closely mirrored the changes observed in SSc patients, suggested that VEGF, hypoxia, and inflammation might play a role in the dysbalance of the Ang/Tie2 system in SSc. This evidence concerns the gene VEGFA and systemic sclerosis.